Kromek Group PLC's (LON:KMK) Dr Arnab Basu speaks to Proactive London's Katie Pilbeam about their results for the six months to October 31, 2020.
For the first half, the company reported an adjusted (EBITDA) loss of £0.9mln compared to a £0.6mln loss in the prior year, while revenues moved to £4.6mln from £5.3mln.
Arnab also details a £1.2mln programme, funded by Innovate UK, to design a system to detect airborne viruses, including coronavirus (COVID-19).
The solution can be used at airports, hospitals, retail outlets and entertainment venues, with the initial focus of the programme being to develop a system to rapidly test for the presence of SARS-CoV-2, the virus that causes COVID-19.
